MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study

MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study

BackgroundTo know the expression of Mesenchymal–Epithelial Transition factor (MET) and Fatty Acid Synthase (FASN) in Triple Negative Breast Cancer (TNBC) patients, as well as its relationship with clinical pathological characteristic and prognosis.Methodswe used immunohistochemistry staining to dete...

Full description

Bibliographic Details
Main Authors: Weihua Jiang, Xiao-Liang Xing, Chenguang Zhang, Lina Yi, Wenting Xu, Jianghua Ou, Ning Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
TNBC
MET
FASN
recurrence
metastasis
prognosis biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.604801/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.604801/full

Similar Items